Gastrografin for Treating Small Bowel Obstruction in Children
The Therapeutic Role of Gastrografin for Treating Small Bowel Obstruction in Children: A Multi-Centre Canadian Prospective Study
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Terminated
Poor recruitment to date.
Other terminated trials from London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
This PHASE2/PHASE3 trial investigates Small Bowel Obstruction and is currently terminated or withdrawn. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's leads this study, which shows 12 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Apr 2025 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jan 2025 — Apr 2025 [monthly]
Terminated PHASE2/PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
Status: Recruiting → Terminated
▶ Show 7 earlier versions
-
May 2022 — Dec 2023 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2021 — May 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Oct 2019 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Feb 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jul 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
For direct contact, visit the study record on ClinicalTrials.gov .